Form 4 for LFST LifeStance Health Group, Inc.
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000950170-25-036734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-10 | 2025-03-06+ | LFST | Bourdon David | CEO, Dir | F - Tax | $7.64 | -89.3K | 817.3K | -10% | -$682.4K |
| M | 2025-03-10 | 2025-03-06+ | LFST | Bourdon David | CEO, Dir | A - Grant | $0.00 | +554.5K | 941.9K | +143% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-06 | F | D | 16,767 | $7.88 | 766,074 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-07 | F | D | 42,816 | $7.59 | 899,123 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-07 | F | D | 29,685 | $7.59 | 817,295 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-07 | A | A | 80,906 | $0.00 | 846,980 | D | — | — | (F3) Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025. |
| 5 | Common | Common Stock | 2025-03-06 | A | A | 348,985 | $0.00 | 782,841 | D | — | — | (F1) Includes 348,985 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 6 | Common | Common Stock | 2025-03-07 | A | A | 124,644 | $0.00 | 941,939 | D | — | — | (F5) Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025. |